In sickness and in health: The functional role of extracellular vesicles in physiology and pathology in vivo: Part II: Pathology
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
It is clear from Part I of this series that extracellular vesicles (EVs) play a critical role in maintaining the homeostasis of most, if not all, normal physiological systems. However, the majority of our knowledge about EV signalling has come from studying them in disease. Indeed, EVs have consistently been associated with propagating disease pathophysiology. The analysis of EVs in biofluids, obtained in the clinic, has been an essential of the work to improve our understanding of their role in disease. However, to interfere with EV signalling for therapeutic gain, a more fundamental understanding of the mechanisms by which they contribute to pathogenic processes is required. Only by discovering how the EV populations in different biofluids change—size, number, and physicochemical composition—in clinical samples, may we then begin to unravel their functional roles in translational models in vitro and in vivo, which can then feedback to the clinic. In Part II of this review series, the functional role of EVs in pathology and disease will be discussed, with a focus on in vivo evidence and their potential to be used as both biomarkers and points of therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101 · cited 2×
“…tumour microenvironment, supporting the formation of the pre-metastatic niche and organotropic metastasis (Costa-Silva et al., 2015; Deng et al., 2017; Fabbri et al., 2012; Hoshino et al., 2015; Keklikoglou et al., 2019; Peinado et al., 2012; H. Zhang, Deng, et al., 2017; L. Zhang et al., 2015).”
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., Becker, A., Hoshino, A., Mark, M. T., Molina, H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3169 · Cited by 2,692
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175 · cited 3×
“…2017; Peinado et al., 2012; Ridger et al., 2017; Siljander et al., 1996; Tominaga et al., 2015; Yates et al., 2019; H. Zhang, Deng, et al., 2017; L. Zhang et al., 2015; Zubairova et al., 2015) leukotrienes via leukotriene 4 synthase, whilst neutrophil EVs deliver arachidonic acid to enable TXa2…”
Fong, M. Y., Zhou, W., Liu, L., Alontaga, A. Y., Chandra, M., Ashby, J., Chow, A., O’Connor, S. T. F., Li, S., Chin, A. R., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3094 · Cited by 1,118
Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00392 · Cited by 1,110
Fang, T., Lv, H., Lv, G., Li, T., Wang, C., Han, Q., Yu, L., Su, B., Guo, L., Huang, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02583-0 · Cited by 995
Tominaga, N., Kosaka, N., Ono, M., Katsuda, T., Yoshioka, Y., Tamura, K., Lötvall, J., Nakagama, H., & Ochiya, T. (2015) · Nature Communications · doi:10.1038/ncomms7716 · Cited by 724
Iba, M., Guo, J. L., McBride, J. D., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2642-12.2013 · Cited by 664 · cited 1×
“For example, in a mouse model of Alzheimer’s disease the propagation of tau fibrils has been shown to be mediated by EVs (Iba et al., 2013) and similar results have been found in mouse models of aging (Ruan et al., 2021).”
Umezu, T., Tadokoro, H., Azuma, K., Yoshizawa, S., Ohyashiki, K., & Ohyashiki, J. H. (2014) · Blood · doi:10.1182/blood-2014-05-576116 · Cited by 600 · cited 1×
“Hypoxic tumour-derived EVs favour angiogenesis in lung and myeloid carcinoma respectively, which may involve miR-23a and miR-135b cargo (Hsu et al., 2017; Umezu et al., 2014).”
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Sardar Sinha, M., Ansell-Schultz, A., Civitelli, L., Hildesjö, C., Larsson, M., Lannfelt, L., Ingelsson, M., & Hallbeck, M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1868-1 · Cited by 527
Valenti, R., Huber, V., Filipazzi, P., Pilla, L., Sovena, G., Villa, A., Corbelli, A., Fais, S., Parmiani, G., & Rivoltini, L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1819 · Cited by 493
Dickens, A. M., Tovar-y-Romo, L. B., Yoo, S.-W., Trout, A. L., Bae, M., Kanmogne, M., Megra, B., Williams, D. W., Witwer, K. W., Gacias, M., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aai7696 · Cited by 285
Self-citationAlzheimer’s disease brain-derived extracellular vesicles spread tau pathology in interneurons
Ruan, Z., Pathak, D., Venkatesan Kalavai, S., Yoshii-Kitahara, A., Muraoka, S., Bhatt, N., Takamatsu-Yukawa, K., Hu, J., Wang, Y., Hersh, S., et al. (2021) · Brain · doi:10.1093/brain/awaa376 · Cited by 283
Cloutier, N., Tan, S., Boudreau, L. H., Cramb, C., Subbaiah, R., Lahey, L., Albert, A., Shnayder, R., Gobezie, R., Nigrovic, P. A., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201846 · Cited by 254 · cited 3×
“Taken from refs: (Agouni et al., 2019; Akbar et al., 2017; Anthony & Couch, 2014; Badimon et al., 2016; Becker et al., 2016; Cloutier et al., 2013; Costa-Silva et al., 2015; Couch, Akbar, Davis et al., 2017; Couch, Akbar, Roodselaar et al., 2017; Deng et al., 2017; Dickens et al., 2017; Fabbri et…”
Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype
McAllister, J. M., Modi, B., Miller, B. A., Biegler, J., Bruggeman, R., Legro, R. S., & Strauss, J. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400574111 · Cited by 250
Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90
Zhang, G., Liu, Z., Ding, H., Zhou, Y., Doan, H. A., Sin, K. W. T., Zhu, Z. J., Flores, R., Wen, Y., Gong, X., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00726-x · Cited by 248
Wysoczynski, M., & Ratajczak, M. Z. (2009) · International Journal of Cancer · doi:10.1002/ijc.24479 · Cited by 216 · cited 1×
“Wysoczynski and Ratajczak (2009) demonstrated that exposing stromal cells to EVs from tumour cells resulted in the stromal cells releasing factors, which encouraged the motility and metastatic capacity of lung cancer cells in vivo (Challagundla et al., 2015).”
Coleman, B. M., & Hill, A. F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.02.007 · Cited by 208
Casella, G., Colombo, F., Finardi, A., Descamps, H., Ill-Raga, G., Spinelli, A., Podini, P., Bastoni, M., Martino, G., Muzio, L., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.06.024 · Cited by 134 · cited 2×
“…disease (CVDs) (Akbar et al., 2017; Amabile et al., 2014; Blonda et al., 2018; Hulsmans & Holvoet, 2013; Jansen et al., 2017; J.-G. Wang et al., 2011), and multiple sclerosis (MS) (Blonda et al., 2018; Casella et al., 2018; Kimura et al., 2018; Sáenz-Cuesta et al., 2014) among others.”
Eitan, E., Hutchison, E. R., Marosi, K., Comotto, J., Mustapic, M., Nigam, S. M., Suire, C., Maharana, C., Jicha, G. A., Liu, D., et al. (2016) · npj Aging and Mechanisms of Disease · doi:10.1038/npjamd.2016.19 · Cited by 129
Platelets: The missing link between the blood and brain?
Leiter, O., & Walker, T. L. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101695 · Cited by 103 · cited 1×
“This interaction may underlie altered pathophysiology in various contexts, from atherosclerosis (Badimon et al., 2016) to brain function (Leiter & Walker, 2019) and angiogenesis (Doser et al., 2009).”
Exosomal GAPDH from Proximal Tubule Cells Regulate ENaC Activity
Jella, K. K., Yu, L., Yue, Q., Friedman, D., Duke, B. J., & Alli, A. A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0165763 · Cited by 81
Cited by
Extracellular Vesicles and Nanoparticles: Emerging Complexities
Jeppesen, D. K., Zhang, Q., Franklin, J. L., & Coffey, R. J. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2023.01.002 · Cited by 705
Comprehensive isolation of extracellular vesicles and nanoparticles
Zhang, Q., Jeppesen, D. K., Higginbotham, J. N., Franklin, J. L., & Coffey, R. J. (2023) · Nature Protocols · doi:10.1038/s41596-023-00811-0 · Cited by 294
Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading
Rädler, J., Gupta, D., Zickler, A., & Andaloussi, S. E. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.013 · Cited by 282
Extracellular vesicles as personalized medicine
Beetler, D. J., Di Florio, D. N., Bruno, K. A., Ikezu, T., March, K. L., Cooper, L. T., Wolfram, J., & Fairweather, D. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101155 · Cited by 101
Li, X., Chen, J., Yang, Y., Cai, H., Ao, Z., Xing, Y., Li, K., Yang, K., Guan, W., Friend, J., et al. (2025) · Microsystems & Nanoengineering · doi:10.1038/s41378-025-00916-4 · Cited by 17
Metadata
- Authors
- Yates, A. G., Pink, R. C., Erdbrügger, U., Siljander, P. R., Dellar, E. R., Pantazi, P., Akbar, N., Cooke, W. R., Vatish, M., Dias‐Neto, E., Anthony, D. C., & Couch, Y.
- Venue
- Journal of Extracellular Vesicles
- Publisher
- Wiley
- Published
- 2022-01
- Volume
- 11
- Issue
- 1
- Pages
- e12190-e12190
- ISSN
- 2001-3078 (ISSN-L)
- OpenAlex
- W4205764319
- Cited by
- 147
- References
- 23
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.